<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180522039775N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-10-20</date_registration>
      <primary_sponsor>Vice Chancellor for Research, Baqiyatallah University of Medical Sciences</primary_sponsor>
      <public_title>Effectiveness of transcranial direct current stimulation in treatment post-traumatic stress disorder</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effectiveness of transcranial direct current stimulation (tDCS) and eye movement desensitization and reprocessing (EMDR) on post-traumatic stress disorder symptoms (PTSD)</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-01-29</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/31383</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: After determining the sample size (60 people), by random allocation rule, 20 patients were assigned to the intervention group 1, 20 to the intervention group 2 and 20 to the control group. For this purpose, 20 balls for the intervention group 1, 20 balls for the intervention group 2 and 20 balls for the control group are placed inside the lottery container, and then the balls are removed from the container without randomize replacement and the resulting sequence is recorded, Blinding description: In this study, participants, researchers, caregivers, and evaluators are blind.  The initial stimulation and appearance of the tDCS device for the target group and the placebo group are quite similar. In the placebo group, after initial stimulation, the tDCS device turns off without notice to the patient, and the device is turned on at the end of the stimulation. Furthermore, patients refer to the clinic at a 90-minute interval in order to reduce the possibility of infiltration of information between them.
The researcher is also unaware of the grouping of participants because the allocation of individuals to groups and the referral to the caregiver is done by a statistician. Also, the implementation and evaluation of the outcome is done by a separate individual
Caregiver and assessing the outcome of the proposal, hypothesis, and type of patients are unaware. Furthermore, in this study, the placebo group also receives a special type of stimulation (primary and secondary), which makes it makes it difficult to diagnose the target group from the placebo for caregivers and evaluators. In other words, the placebo group does not end the treatment sessions without stimulation. Therefore, the identification of the placebo and target group is difficult.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Post-traumatic stress disorder (PTSD).</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: In this group, direct current stimulation was delivered from a battery-driven (Neurosoft, Russia), constant current stimulator and transferred by a pair of 5×7 (35cm2) electrodes. Electrodes were standard carbonic, covered with a normal saline socked sponge cases. In this study, intervention group 1 received real transcranial direct current stimulation (tDCS). In this case, based on the 10-20 system the cathode electrode was placed on right dorsolateral prefrontal cortex (rdLPFC) and anode electrode was placed on the left  dorsolateral prefrontal cortex (ldLPFC). 2 mA current for 20 minutes was passed from patient's brain at 10 session. Intervention 2: Intervention group 2: In this group, eye movement desensitization and reprocessing (EMDR) is applied during 45minutes in 5 sessions. For this purpose, EMDR is performed in eight steps:  Patient history and treatment planning, preparation, assessment, desensitization, Installation, body scan, clousr and reevaluation. Intervention 3: control group: This group received sham transcranial direct current stimulation (tDCS). For sham stimulation, the same methods of placing anode and cathode were used, however, the stimulator was ramped-up to 2 mA in 30s, then gradually ramped-down to 0 mA over the period of 1 minute, and then turned off. The electrodes were on the scalp for 20 minutes and subjects were not informed that the device is turned off.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The total potential data can be shared after unidentifiable people

When:
Start the access period 7 months after publishing the results

To whom:
Data will be available to researchers working in universities and academic institutions

Conditions:
for scientific use only

Where to obtain:
Mehdi Rezaei- Tel: 00989383354916- E-mail: Rezaee.mehdi15@yahoo.com

How to obtain:
The applicant will receive the data within a maximum of one week by explaining the reason for requesting

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mehdi Rezaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Behavioral Science Research Center, Baqiyatallah University of Medical Sciences,  Molla-Sadra Sreet, Vanak Sq</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3766152624</zip>
        <telephone>+98 21 5675 9071</telephone>
        <email>Rezaee.mehdi15@yahoo.com</email>
        <affiliation>Bagheiat-allah University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mehdi Rezaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Behavioral Science Research Center, Baqiyatallah University of Medical Sciences,  Molla-Sadra Sreet, Vanak Sq</address>
        <city>Baharestan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3766152624</zip>
        <telephone>+98 21 5675 9071</telephone>
        <email>Rezaee.mehdi15@yahoo.com</email>
        <affiliation>Bagheiat-allah University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age of 18 to 60 years
Sign the informed consent form
Post-traumatic stress disorder
Having a PTSD checklist version (PCL-5)  greater than 50
Experienced no change in psychosocial treatments for 2 months before tDCS
Experienced no change in psychotropic medication</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Axis 1 psychiatric disorders or personality disorders.
A history of a significant neurological or medical disorder such as seizure, brain tumors, traumatic brain injury , stroke, Parkinson’s disease, dementia, Huntington’s chorea, multiple sclerosis
Changed  medications in the 8 weeks prior to commencement of the trial
Implanted medication pumps of any sort that would increase the risk of tDCS
The risk of Seizure with any reasons, high Intracranial pressure, The history of epilepsy or Seizure in the first relatives, any metal in Head, brain trauma, history of loss of consciousness for more than 5 minutes
Pregnancy, breastfeeding
High risk of Suicide</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F43.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Post-traumatic stress disorder (PTSD)</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Behavior</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: In this group, direct current stimulation was delivered from a battery-driven (Neurosoft, Russia), constant current stimulator and transferred by a pair of 5×7 (35cm2) electrodes. Electrodes were standard carbonic, covered with a normal saline socked sponge cases. In this study, intervention group 1 received real transcranial direct current stimulation (tDCS). In this case, based on the 10-20 system the cathode electrode was placed on right dorsolateral prefrontal cortex (rdLPFC) and anode electrode was placed on the left  dorsolateral prefrontal cortex (ldLPFC). 2 mA current for 20 minutes was passed from patient's brain at 10 session.</i_keyword>
      <i_keyword>Intervention group 2: In this group, eye movement desensitization and reprocessing (EMDR) is applied during 45minutes in 5 sessions. For this purpose, EMDR is performed in eight steps:  Patient history and treatment planning, preparation, assessment, desensitization, Installation, body scan, clousr and reevaluation</i_keyword>
      <i_keyword>control group: This group received sham transcranial direct current stimulation (tDCS). For sham stimulation, the same methods of placing anode and cathode were used, however, the stimulator was ramped-up to 2 mA in 30s, then gradually ramped-down to 0 mA over the period of 1 minute, and then turned off. The electrodes were on the scalp for 20 minutes and subjects were not informed that the device is turned off.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Score of PTSD on post-traumatic stress index (PCL-5). Timepoint: Before intervention, Final session, one month after intervention. Method of measurement: Post-traumatic stress index (PCL-5).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Score of anxiety. Timepoint: Before intervention, final session ,one month after intervention. Method of measurement: Beck Anxiety Inventory.</sec_outcome>
      <sec_outcome>Score of depression. Timepoint: Before intervention, final session ,one month after intervention. Method of measurement: Beck Depression Inventory (BDI-II).</sec_outcome>
      <sec_outcome>Score of rumination. Timepoint: Before intervention, final session ,one month after intervention. Method of measurement: Ruminative Response Scale (RRS).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice Chancellor for Research, Baqiyatallah University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-12-11</approval_date>
        <contact_name>Ethics committee of Baqiyatallah University of Medical Sciences</contact_name>
        <contact_address>Behavioral Science Research Center, Baqiyatallah University of Medical Sciences, Sheykh Bahaei Ave, Molla Sadra Ave, Vanak square Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
